2 TRiM Platform for Delivery of RNAi Therapeutics to Central Nervous System via Subcutaneous Administration Agnieszka Glebocka, Ph.D. Vice President, Discovery Chemistry Arrowhead Pharmaceuticals Safe Harbor Statement This presentation contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These statements are based upon our current expectations and speak only as of the date hereof. Our actual results may differ materia ...